Replies to post #81841 on Intellicell Biosciences Inc (fka SVFC)

[HAE12]

Anyone who has had contact with SVFC---is it possible to ask them OUTRIGHT if they now COMPLETELY "fall under' the new FDA guidelines for being minimally manipulated?

[BigBadWolf]

$$Completely $$FALSE as of now this has $$NOT happened

Fda steps out of the way!

$$So $$More $$Hope $$Hype $$Failed $$Dreams $$SVFC $$Nightmares $$Since .078 in 7-12-2013 to 0001 again today 11/13/14 $$coincide with $$declining $$shareholder $$value $$Billions of $$shares $$trading @ 000485 w/ $$NO $$Bid

From the Link Provided

New FDA-
Proposed Guidelines

Again $$No where does it say this

Fda steps out of the way!

so $$another $$SVFC $$Falsehood $$More $$Hope $$Hype as $$Verified by the link provided As a proposed guideline is just this, shown below

Full Definition of PROPOSE
intransitive verb
1. to form or put forward a plan or intention

guideline
n.noun

A statement or other indication of policy or procedure by which to determine a course of action.

Also From the Link Provided is this disclaimer

DISCLAIMERS
Some companies that Maxim Group LLC follows are emerging growth companies whose securities typically involve a higher degree of risk and more volatility than the securities of more established companies. The securities discussed in Maxim Group LLC research reports may not be suitable for some investors. Investors must make their own determination as to the appropriateness of an investment in any securities referred to herein, based on their specific investment objectives, financial status and risk tolerance. This communication is neither an offer to sell nor a solicitation of an offer to buy any securities mentioned herein. This publication is confidential for the information of the addressee only and may not be reproduced in whole or in part, copies circulated, or disclosed to another party, without the prior written consent of Maxim Group, LLC (“Maxim”).
Information and opinions presented in this report have been obtained or derived from sources believed by Maxim to be reliable, but Maxim makes no representation as to their accuracy or completeness. The aforementioned sentence does not apply to the disclosures required by NASD Rule 2711. Maxim accepts no liability for loss arising from the use of the material presented in this report, except that this exclusion of liability does
not apply to the extent that such liability arises under specific statutes or regulations applicable to Maxim. This report is not to be relied upon in substitution for the exercise of independent judgment. Maxim may have issued, and may in the future issue, other reports that are inconsistent with,
and reach different conclusions from, the information presented in this report. Those reports reflect the different assumptions, views and analytical methods of the analysts who prepared them and Maxim is under no obligation to ensure that such other reports are brought to the attention of any recipient of this report.
Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Information, opinions and estimates contained in this report reflect a judgment at its original date of publication
by Maxim and are subject to change without notice. The price, value of and income from any of the securities mentioned in this report can fall as well as rise. The value of securities is subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities. Investors in securities such as ADRs, the values of which are influenced by currency volatility, effectively assume this risk. Securities recommended, offered or sold by Maxim: (1) are not insured by the Federal Deposit Insurance Company; (2) are not deposits or other obligations of any insured depository institution; and (3) are subject to investment risks, including the possible loss of principal invested. Indeed, in the case
of some investments, the potential losses may exceed the amount of initial investment and, in such circumstances, you may be required to pay more money to support these losses.

$$Author

Jason Kolbert
[phone]
[e-mail]